Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Givaudan SA    GIVN   CH0010645932

GIVAUDAN SA

(GIVN)
  Report
Delayed Quote. Delayed Swiss Exchange - 10/21 11:30:45 am
3873 CHF   -0.92%
10/19GIVAUDAN AG : UBS reiterates its Buy rating
MD
10/09GIVAUDAN AG : Deutsche Bank sticks Neutral
MD
10/09GIVAUDAN AG : Berenberg reiterates its Buy rating
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
10/15/2020 10/16/2020 10/19/2020 10/20/2020 10/21/2020 Date
3951(c) 3968(c) 3935(c) 3909(c) 3873 Last
26 462 27 459 12 101 19 180 24 225 Volume
-2.08% +0.43% -0.83% -0.66% -0.92% Change
More quotes
Financials
Sales 2020 6 436 M 7 120 M 7 120 M
Net income 2020 791 M 875 M 875 M
Net Debt 2020 3 881 M 4 293 M 4 293 M
P/E ratio 2020 45,6x
Yield 2020 1,65%
Sales 2021 6 670 M 7 379 M 7 379 M
Net income 2021 870 M 962 M 962 M
Net Debt 2021 3 659 M 4 048 M 4 048 M
P/E ratio 2021 41,7x
Yield 2021 1,72%
Capitalization 36 076 M 39 763 M 39 909 M
EV / Sales 2020 6,21x
EV / Sales 2021 5,96x
Nbr of Employees 15 847
Free-Float 86,0%
More Financials
Company
Givaudan SA is one of the world's leading producers of flavors and perfumes. Net sales break down by family of products as follows: - flavors (54.9%): for producing salted side dishes (38% of sales; prepared dishes, snacks, soups and sauces, meat and poultry), beverages (32%; sodas, fruit juices, instant beverages), sweet goods (17%), and dairy products (13%); - perfumes (45.1%): intended to the production of... 
Sector
Specialty Chemicals
Calendar
11/04Präsentation
More about the company
Notations Surperformance© of Givaudan SA
Trading Rating : Investor Rating :
More Ratings
All news about GIVAUDAN SA
10/19GIVAUDAN AG : UBS reiterates its Buy rating
MD
10/09GIVAUDAN AG : Deutsche Bank sticks Neutral
MD
10/09GIVAUDAN AG : Berenberg reiterates its Buy rating
MD
10/08GLOBAL MARKETS LIVE : Gilead sells Remdesivir to the E.U, Morgan Stanley’s new a..
10/08GIVAUDAN AG : Goldman Sachs gives a Sell rating
MD
10/08GIVAUDAN AG : Gets a Sell rating from Bernstein
MD
10/08GIVAUDAN AG : Morgan Stanley gives a Neutral rating
MD
10/08GIVAUDAN AG : JP Morgan reiterates its Neutral rating
MD
10/08GIVAUDAN AG : Baader Bank keeps its Buy rating
MD
10/08GIVAUDAN : Sales Flat in 3Q as Pandemic Weighed on Business
DJ
10/08GIVAUDAN : sales growth accelerates in third quarter as perfumes improve
RE
10/08GIVAUDAN SA : 3rd quarter results
CO
10/07GIVAUDAN AG : UBS maintains a Buy rating
MD
10/05GIVAUDAN SA : quaterly sales release
10/01GIVAUDAN AG : JP Morgan gives a Neutral rating
MD
More news
News in other languages on GIVAUDAN SA
10/19GIVAUDAN AG : Opinion positive de UBS
10/15Givaudan inaugure un nouveau site pour la production de parfums en Chine
10/15Givaudan eröffnet in China Produktionsstätte für Duftstoffe
10/14Aktien Zürich Schluss: Verunsicherung belastet - SMI unter 10 300 Punkten
10/14Aktien Schweiz Schluss: Verunsicherung belastet - SMI unter 10'300 Punkten
More news
Analyst Recommendations on GIVAUDAN SA
More recommendations
Chart GIVAUDAN SA
Duration : Period :
Givaudan SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GIVAUDAN SA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Average target price 3 572,96 CHF
Last Close Price 3 909,00 CHF
Spread / Highest target 15,1%
Spread / Average Target -8,60%
Spread / Lowest Target -42,4%
EPS Revisions
Managers
NameTitle
Gilles Andrier Chief Executive Officer
Calvin Grieder Chairman
Tom Hallam Chief Financial Officer
Thomas Rufer Non-Executive Director
Lilian Margareta Fossum Biner Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GIVAUDAN SA28.97%39 763
ECOLAB INC.5.19%57 936
SIKA AG26.48%35 932
EMS-CHEMIE HOLDING AG33.46%21 900
SYMRISE AG22.97%18 478
CRODA INTERNATIONAL PLC25.00%10 605